\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ the\\ patient\\ is\\ a\\ white\\ male\\.\\ he\\ is\\ 170\\.2cm\\ tall\\ and\\ weighs\\ about\\ 98\\.7\\ kg\\ \\(bmi\\ 34\\.1\\)\\.\\ blood\\ pressure\\ on\\ the\\ left\\ arm\\ in\\ the\\ seated\\ position\\ is\\ 129\\/64\\.\\ appears\\ stated\\ age\\.\\ he\\ is\\ well\\ appearing\\ and\\ in\\ no\\ acute\\ distress\\.\ \(0\)\
\-\ heent\\ \\:\\ normocephalic\\,\\ non\\ traumatic\\.\\ pupils\\ were\\ equal\\ and\\ reactive\\ to\\ light\\.\\ \ \(0\)\
\-\ cardiac\\:\\ regular\\ rate\\ and\\ rhythm\\,\\ normal\\ s1\\ and\\ s2\\.\\ no\\ murmurs\\,\\ rubs\\,\\ or\\ gallops\\.\\ right\\ sided\\ scars\\ visible\\ from\\ healed\\ vats\\.\\ median\\ sternotomy\\ incision\\ is\\ well\\ healed\\.\\ \ \(0\)\
\-\ pulmonary\\ \\:\\ pattern\\ unlabored\\,\\ breath\\ sounds\\ are\\ clear\\ and\\ equal\\ bilaterally\\,\\ no\\ distress\\.\\ no\\ rales\\,\\ no\\ rhonchi\\,\\ no\\ wheezez\\.\ \(0\)\
\-\ abdomen\\:\\ non\\-distended\ \(0\)\
\-\ extremities\\:\\ no\\ cyanosis\\,\\ no\\ clubbing\\,\\ no\\ edema\\,\\ no\\ coolness\\ and\\ no\\ deformities\\.\\ \ \(0\)\
\-\ musculoskeletal\\:\\ 5\\+\\ muslce\\ strength\\ in\\ all\\ extremities\\,\\ gait\\ and\\ tone\\ are\\ normal\\.\ \(0\)\
\-\ this\\ patient\\ was\\ initially\\ treated\\ with\\ right\\ thoracotomy\\,\\ which\\ yielded\\ 2l\\ of\\ fluid\\.\\ this\\ procedure\\ significantly\\ improved\\ his\\ shortness\\ of\\ breath\\.\\ \ \(0\)\
\-\ he\\ then\\ underwent\\ a\\ right\\ vats\\ pleurectomy\\ and\\ was\\ then\\ referred\\ to\\ outpatient\\ an\\ outpatient\\ medical\\ oncologist\\ who\\ is\\ currently\\ managing\\ his\\ treatment\\.\ \(0\)\
\-\ he\\ currently\\ on\\ chemotherapy\\ under\\ supervision\\ of\\ a\\ medical\\ oncologist\\,\\ and\\ reports\\ that\\ he\\ is\\ doing\\ well\\.\ \(0\)\
\-\ images\\ 1\\ and\\ 2\\ represent\\ a\\ pre\\-operative\\ pet\\-ct\\.\\ the\\ patient\\ was\\ given\\ iv\\ 18f\\-fdg\\ followed\\ by\\ low\\-dose\\,\\ non\\ contrast\\ ct\\ from\\ the\\ skull\\ vertex\\ to\\ the\\ mid\\-thigh\\.\\ this\\ ct\\ was\\ obtained\\ for\\ attenuation\\ correction\\ and\\ anatomic\\ orientation\\ with\\ axial\\ reconstruction\\.\\ pet\\ followed\\,\\ encompassing\\ the\\ same\\ regions\\.\\ the\\ chest\\ was\\ found\\ to\\ show\\ mild\\ to\\ moderate\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleural\\ effusion\\/thickening\\.\\ \\ there\\ was\\ a\\ small\\ internal\\ decrease\\ in\\ size\\.\\ there\\ was\\ no\\ axillary\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ there\\ is\\ no\\ air\\-space\\ disease\\ or\\ suspicious\\ lung\\ nodule\\.\\ these\\ findings\\ are\\ consistent\\ with\\ low\\-grade\\ metabolically\\ active\\ malignant\\ epithelioid\\ neoplasm\\ consistent\\ with\\ mesothelioma\\ of\\ the\\ right\\-sided\\ pleura\\.\\ \ \(0\)\
\-\ image\\ 3\\ represents\\ erect\\ pa\\ and\\ lateral\\ chest\\ images\\ following\\ vats\\ pleurectomy\\.\\ these\\ films\\ demonstrate\\ post\\-sternotomy\\ midline\\ wires\\ and\\ clips\\.\\ of\\ note\\ there\\ is\\ mild\\ to\\ moderate\\ cardiomegaly\\ and\\ chronic\\ right\\ basolateral\\ pleural\\ thickening\\ of\\ the\\ inferior\\ right\\ minor\\ fissure\\.\\ a\\ mediport\\-type\\ catheter\\ is\\ visualized\\ overlying\\ the\\ superior\\ right\\ hemithorax\\ with\\ its\\ distal\\ extent\\ projecting\\ over\\ the\\ course\\ of\\ the\\ right\\ jugular\\ vein\\.\\ there\\ is\\ also\\ minor\\ bronchitis\\ interstitial\\ features\\ at\\ the\\ lung\\ bases\\.\\ there\\ is\\ no\\ acute\\ pathology\\ noted\\,\\ and\\ there\\ is\\ no\\ evidence\\ of\\ pneumothorax\\ or\\ definitive\\ infiltrates\\.\ \(0\)\
\-\ image\\ 4\\ represents\\ a\\ follow\\ up\\ study\\ approximately\\ 2\\ weeks\\ after\\ image\\ 3\\ was\\ obtained\\.\\ there\\ was\\ evidence\\ of\\ copd\\.\\ it\\ was\\ noted\\ that\\ there\\ was\\ pleural\\-parenchymal\\ scarring\\ of\\ the\\ right\\ lung\\ base\\.\\ the\\ same\\ medial\\ sternotomy\\ changes\\ were\\ noted\\,\\ as\\ was\\ the\\ mediport\\ placement\\ and\\ cardiomegaly\\.\\ at\\ this\\ point\\ there\\ was\\ no\\ active\\ pulmonary\\ disease\\ noted\\.\\ \ \(0\)\
\-\ images\\ 5\\,\\ 6\\,\\ and\\ 7\\ represent\\ post\\-operative\\ pet\\-ct\\ following\\ right\\-sided\\ vats\\ pleurectomy\\.\\ the\\ same\\ protocol\\ was\\ followed\\ as\\ for\\ the\\ pet\\-ct\\ shown\\ in\\ images\\ 1\\ and\\ 2\\.\\ there\\ was\\ found\\ to\\ be\\ minimal\\ abnormal\\ fdg\\ uptake\\ within\\ the\\ right\\-sided\\ pleura\\.\\ there\\ was\\ no\\ axillary\\,\\ supraclavicular\\,\\ mediastinal\\,\\ or\\ hilar\\ lymphadenopathy\\.\\ the\\ image\\ has\\ the\\ overall\\ appearance\\ of\\ postsurgical\\ inflammatory\\ changes\\,\\ although\\ residual\\ low\\-grade\\ metabolically\\ active\\ metastasis\\ cannot\\ be\\ excluded\\.\ \(0\)\
\-\ malignant\\ mesothelioma\\,\\ epithelioid\\ type\ \(0\)\
\-\ asbestosis\ \(10\)\
\-\ malignant\\ mesothelioma\ \(14\)\
\-\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ male\\ who\\ presented\\ to\\ his\\ primary\\ care\\ physician\\ as\\ part\\ of\\ a\\ pre\\-operative\\ work\\-up\\ for\\ cataract\\ surgery\\.\\ on\\ cxr\\ it\\ was\\ noted\\ that\\ the\\ patient\\ has\\ a\\ pleural\\ effusion\\.\\ the\\ patient\\ did\\ note\\ that\\ he\\ had\\ increasing\\ shortness\\ of\\ breath\\,\\ but\\ did\\ not\\ think\\ to\\ address\\ this\\ issue\\ prior\\ to\\ his\\ pre\\-op\\ clearance\\.\\ \ \(0\)\
\-\ pmhx\\:\\ \ \(0\)\
\-\ gerd\\,\\ gout\\,\\ hyperlipidemia\\,\\ benign\\ tumor\\ of\\ colon\\,\\ osteoarthritis\\,\\ rheumatic\\ fever\\,\\ htn\\,\\ congestive\\ heart\\ failure\\,\\ cad\\,\\ myocardial\\ infarction\ \(0\)\
\-\ pshx\\:\\ \ \(0\)\
\-\ neck\\ surgery\\ in\\ childhood\\ \\(ages\\ 5\\ and\\ 10\\)\\,\\ cholecystecomy\\ s\\/p\\ gallbladder\\ rupture\\,\\ quadruple\\ bypass\\ surgery\\,\\ hemicolectomy\\,\\ avulsed\\ fingers\\,\\ vats\\,\\ right\\ pleurectomy\ \(0\)\
\-\ medications\\:\\ almethicone\\ 125mg\\,\\ albuterol\\-ipratropium\\,\\ oxycodone\\ 10mg\\,\\ senna\\ oral\\,\\ tamsulosin\\,\\ alprazolam\\,\\ isosorbide\\ mononitrate\\,\\ plavix\\,\\ aspirin\\,\\ lipitor\\,\\ allopurinol\\,\\ atenolol\\,\\ ranitidine\\,\\ fluoxetine\\,\\ nitroglycerin\\,\\ ferrous\\ sulfate\\.\\ \ \(0\)\
\-\ allergies\\:\\ adhesive\\ tape\\ \\(rash\\)\ \(0\)\
\-\ transfusions\\:\\ the\\ patient\\ has\\ had\\ 2\\ blood\\ transfusions\\ as\\ a\\ result\\ of\\ rectal\\ bleeding\\ from\\ gi\\ tumors\\.\ \(0\)\
\-\ social\\:\\ 34\\ pack\\ year\\ smoking\\ histroy\\ \\(2\\ ppd\\ for\\ 17\\ years\\)\\,\\ quit\\ smoking\\ in\\ 1970\\.\\ history\\ of\\ alcohol\\ abuse\\,\\ sober\\ since\\ 2012\\ when\\ he\\ underwent\\ treatment\\ for\\ etoh\\ withdrawal\\.\\ he\\ denies\\ any\\ illicit\\ and\\/or\\ iv\\ drug\\ abuse\\.\\ \\ the\\ patient\\ has\\ 3\\ children\\.\\ he\\ lives\\ in\\ an\\ apartment\\ on\\ his\\ house\\,\\ which\\ his\\ daughter\\ occupies\\.\\ he\\ worked\\ as\\ at\\ chemical\\ plant\\ for\\ 40\\ years\\.\\ he\\ recalls\\ this\\ plant\\ is\\ adjacent\\ to\\ another\\ chemical\\ plant\\ which\\ used\\ asbestos\\ as\\ part\\ of\\ its\\ plastics\\ manufacturing\\ process\\.\ \(0\)\
\-\ nathan\\ kronenwetter\\,\\ ms\\ iv\\;\\ frank\\ mascaro\\,\\ md\\;\\ randall\\ loftus\\,\\ md\\;\\ joanna\\ garvey\\,\\ dc\\;\\ robert\\ lutnick\\,\\ md\\;\\ scott\\ croce\\,\\ dc\\;\\ gary\\ smith\\,\\ dc\\;\\ krishnan\\ kartha\\,\\ md\\;\\ joseph\\ serghany\\,\\ md\\;\\ charles\\ tirone\\,\\ md\\,\\ vaseem\\ iqbal\\,\\ md\\;\\ jennifer\\ sperrazza\\,\\ dc\\;\\ jeffrey\\ lieberman\\,\\ md\\;\\ geoffrey\\ gerow\\,\\ dc\\.\\ \\ this\\ patient\\ is\\ a\\ 77\\ year\\ old\\ white\\ male\\.\\ he\\ worked\\ in\\ a\\ factory\\ adject\\ to\\ a\\ chemical\\ plant\\,\\ which\\ used\\ asbestos\\ in\\ the\\ manufacturing\\ of\\ plastic\\ products\\.\\ he\\ states\\ that\\ he\\ remembers\\ hearing\\ that\\ during\\ the\\ day\\,\\ the\\ plant\\ would\\ vacuum\\ excess\\ asbestos\\ from\\ the\\ factory\\ floor\\ to\\ the\\ roof\\ of\\ the\\ building\\ and\\ then\\ vent\\ the\\ asbestos\\ out\\ the\\ stacks\\ of\\ the\\ factory\\ at\\ night\\.\\ in\\ fact\\,\\ the\\ patient\\'s\\ grown\\ son\\,\\ now\\ in\\ his\\ fifties\\,\\ recalls\\ there\\ often\\ being\\ a\\ thin\\ coating\\ of\\ \\?dust\\?\\ on\\ park\\ benches\\ in\\ the\\ morning\\ following\\ the\\ venting\\ from\\ the\\ plant\\.\\ \ \(0\)\
\-\ the\\ patient\\ states\\ that\\ he\\ worked\\ in\\ a\\ plant\\ approximately\\ 600\\ feet\\ from\\ the\\ asbestos\\-using\\ facility\\,\\ and\\ states\\ that\\ his\\ factory\\ was\\ under\\ negative\\ pressure\\,\\ resulting\\ in\\ outside\\ asbestos\\-containing\\ air\\ to\\ be\\ \\?sucked\\ into\\?\\ his\\ factory\\.\\ he\\ began\\ work\\ in\\ the\\ 1960s\\ and\\ worked\\ at\\ the\\ same\\ plant\\ for\\ 41\\ years\\ until\\ his\\ retirement\\ in\\ 2003\\.\\ he\\ also\\ lived\\ approximately\\ 1\\ mile\\ from\\ both\\ plants\\,\\ and\\ states\\ that\\ his\\ home\\ was\\ directly\\ downwind\\ from\\ the\\ factories\\.\\ unfortunately\\,\\ this\\ patient\\ reported\\ that\\ a\\ former\\ coworker\\ died\\ of\\ complications\\ from\\ mesothelioma\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ mesothelioma\\ was\\ discovered\\ incidentally\\ as\\ part\\ of\\ pre\\-operative\\ clearance\\ for\\ a\\ propsed\\ opthalmologic\\ surgery\\.\\ as\\ part\\ of\\ his\\ pre\\-operative\\ work\\-up\\ a\\ chest\\ xray\\ was\\ ordered\\,\\ which\\ revealed\\ a\\ large\\ plueral\\ effusion\\.\\ he\\ recalls\\ that\\ at\\ the\\ time\\ of\\ discovery\\ he\\ did\\ have\\ shortness\\ of\\ breath\\ with\\ minimal\\ exersion\\,\\ stating\\ that\\ he\\ would\\ become\\ short\\ of\\ breath\\ \\?just\\ by\\ talking\\?\\.\\ \ \(0\)\
\-\ this\\ patient\\'s\\ case\\ is\\ typical\\ of\\ malignant\\ pleural\\ mesothelioma\\.\\ this\\ disease\\ typically\\ affects\\ patients\\ who\\ are\\ 60\\ years\\ and\\ older\\.\\ often\\,\\ these\\ patients\\ present\\ decades\\ after\\ an\\ exposure\\ to\\ asbestos\\ and\\ have\\ gradual\\,\\ worsening\\,\\ nonspecific\\ pulmonary\\ symptoms\\ including\\ but\\ not\\ limited\\ to\\:\\ chest\\ pain\\,\\ dyspnea\\,\\ cough\\,\\ hoarseness\\,\\ or\\ dysphagia\\.\ \(0\)\
\-\ physical\\ findings\\ at\\ the\\ time\\ of\\ diagnosis\\ generally\\ are\\ related\\ to\\ a\\ pleural\\ effusion\\,\\ which\\ is\\ often\\ present\\.\\ physical\\ exam\\ findings\\ may\\ include\\ unilateral\\ dullness\\ to\\ percussion\\ at\\ the\\ lung\\ base\\,\\ decreased\\ air\\ movement\\ on\\ side\\ of\\ involvement\\,\\ or\\ asymmetric\\ chest\\ wall\\ expansion\\ during\\ respiration\\ \\(2\\-6\\)\\.\ \(0\)\
\-\ the\\ primary\\ risk\\ factor\\ for\\ mesothelioma\\ is\\ asbestos\\ exposure\\.\\ the\\ fibers\\ of\\ asbestos\\,\\ a\\ naturally\\ occuring\\ mineral\\,\\ are\\ strong\\ and\\ resistant\\ to\\ heat\\,\\ and\\ have\\ been\\ used\\ in\\ the\\ production\\ of\\ insulation\\,\\ brakes\\,\\ shingles\\,\\ flooring\\ and\\ many\\ other\\ products\\.\\ if\\ asbestos\\ is\\ broken\\ up\\,\\ and\\ the\\ dust\\ is\\ inhaled\\ or\\ swallowed\\,\\ the\\ fibers\\ will\\ settle\\ in\\ the\\ lungs\\,\\ leading\\ to\\ irritation\\,\\ which\\ can\\ then\\ progress\\ to\\ mesothelioma\\.\\ the\\ exact\\ mechanism\\ of\\ this\\ malignant\\ transformation\\ is\\ poorly\\ understood\\.\\ the\\ development\\ of\\ mesothelioma\\ following\\ asbestos\\ exposure\\ may\\ be\\ a\\ \\ 20\\ \\-\\ 40\\ year\\ process\\.\\ of\\ note\\,\\ most\\ people\\ with\\ years\\ of\\ asbestos\\ exposure\\ never\\ develop\\ mesothelioma\\,\\ while\\ some\\ people\\,\\ with\\ only\\ minimal\\ exposure\\,\\ develop\\ the\\ disease\\.\\ given\\ this\\ variation\\,\\ a\\ predisposition\\ to\\ cancer\\ likely\\ plays\\ a\\ role\\ in\\ disease\\ progression\\.\\ additional\\ risk\\ factors\\ include\\,\\ living\\ with\\ someone\\ working\\ with\\ asbestos\\ \\(as\\ they\\ may\\ carry\\ the\\ fibers\\ home\\ on\\ their\\ clothing\\ and\\ skin\\)\\,\\ as\\ well\\ as\\ family\\ history\\ of\\ mesothelioma\\ \\(7\\-\\ 9\\)\\.\ \(0\)\
\-\ in\\ terms\\ of\\ imaging\\,\\ computed\\ tomography\\ \\(ct\\)\\ is\\ often\\ pursued\\ given\\ limited\\ sensitivity\\ and\\ specificity\\ with\\ cxr\\.\\ findings\\ include\\ unilateral\\ pleural\\ abnormalities\\ with\\ a\\ large\\ unilateral\\ pleural\\ effusion\\.\\ there\\ may\\ be\\ a\\ plural\\ mass\\ or\\ \\"rind\\"\\,\\ or\\ even\\ a\\ diffuse\\ pleural\\ thickening\\ in\\ the\\ absence\\ of\\ pleural\\ effusion\\.\\ there\\ can\\ be\\ ipsilateral\\ mediastinal\\ shift\\ due\\ to\\ encasement\\ of\\ the\\ lung\\ by\\ a\\ thick\\ \\"rind\\"of\\ tumor\\ and\\ relative\\ ipsilateral\\ lung\\ volume\\ loss\\.\\ when\\ positron\\ emission\\ tomography\\ \\(pet\\)\\ is\\ used\\ in\\ conjunction\\ with\\ ct\\,\\ \\ increased\\ uptake\\ of\\ fluorodeoxyglucose\\ \\(fdg\\)\\ is\\ observed\\.\ \(0\)\
\-\ for\\ the\\ diagnosis\\ of\\ malignant\\ mesothelioma\\,\\ clinical\\ suspicion\\ may\\ arise\\ with\\ respiratory\\ symptoms\\,\\ pleural\\ thickening\\ and\\/or\\ effusion\\ on\\ chest\\ imaging\\,\\ and\\ a\\ history\\ of\\ asbestos\\ exposure\\.\\ however\\,\\ ultimately\\,\\ a\\ biopsy\\ is\\ necessary\\ to\\ confirm\\ the\\ diagnosis\\.\ \(0\)\
\-\ once\\ diagnosed\\,\\ an\\ integrated\\ positron\\ emission\\ tomography\\ with\\ computed\\ tomography\\ \\(pet\\-ct\\)\\ is\\ the\\ initial\\ staging\\ assessment\\.\ \(0\)\
\-\ when\\ diagnosed\\ at\\ an\\ early\\ stage\\,\\ surgeons\\ may\\ remove\\ the\\ mesothelioma\\,\\ and\\ in\\ some\\ cases\\,\\ this\\ may\\ be\\ curative\\.\\ other\\ therapies\\ include\\ chemotherapy\\ and\\ radiation\\ therapy\\.\\ there\\ are\\ ongoing\\ clinical\\ trials\\ investigating\\ targeted\\ biological\\ and\\ gene\\ therapy\\.\ \(0\)\
\-\ overall\\,\\ however\\,\\ the\\ prognosis\\ is\\ poor\\.\\ the\\ survival\\ is\\ on\\ the\\ spectrum\\ of\\ 9\\ to\\ 17\\ months\\ after\\ diagnosis\\ and\\ few\\ patients\\ are\\ cured\\ \\(12\\)\\.\ \(0\)\
\-\ references\\ for\\ malignant\\ pleural\\ mesothelioma\ \(0\)\
\-\ 1\\.\\ husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ 2\\.\\	socola\\ f\\,\\ loaiza\\-bonilla\\ a\\,\\ bustinza\\-linares\\ e\\,\\ et\\ al\\.\\ recurrent\\ thrombotic\\ thrombocytopenic\\ purpura\\-like\\ syndrome\\ as\\ a\\ paraneoplastic\\ phenomenon\\ \\ in\\ malignant\\ peritoneal\\ mesothelioma\\:\\ a\\ case\\ report\\ and\\ review\\ of\\ the\\ literature\\.\\ case\\ rep\\ oncol\\ med\\ 2012\\;\\ \\ 2012\\:619348\\.\ \(0\)\
\-\ 3\\.\\	wong\\ sf\\,\\ newland\\ l\\,\\ john\\ t\\,\\ white\\ sc\\.\\ paraneoplastic\\ leukocytoclastic\\ vasculitis\\ as\\ an\\ initial\\ presentation\\ \\ of\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ case\\ report\\.\\ j\\ med\\ case\\ rep\\ 2012\\;\\ 6\\:261\\.\ \(0\)\
\-\ 4\\.\\	li\\ jy\\,\\ yong\\ ty\\,\\ kuss\\ bj\\,\\ et\\ al\\.\\ malignant\\ pleural\\ mesothelioma\\ with\\ associated\\ minimal\\ change\\ disease\\ and\\ acute\\ renal\\ \\ failure\\.\\ ren\\ \\ fail\\ 2010\\;\\ 32\\:1012\\.\ \(0\)\
\-\ 5\\.\\	bech\\ c\\,\\ s0rensen\\ jb\\.\\ polyneuropathy\\ \\ in\\ a\\ patient\\ with\\ malignant\\ pleural\\ mesothelioma\\:\\ \\ a\\ paraneoplastic\\ \\ syndrome\\.\\ j\\ thorac\\ oncol\\ \\ 2008\\;\\ \\ 3\\:1359\\.\ \(0\)\
\-\ 6\\.\\	tanriverdi\\ 0\\,\\ meydan\\ n\\,\\ barutca\\ s\\,\\ et\\ al\\.\\ anti\\-yo\\ antibody\\-mediated\\ paraneoplastic\\ cerebellar\\ degeneration\\ in\\ a\\ female\\ patient\\ with\\ pleural\\ malignant\\ mesothelioma\\.\\ jpn\\ j\\ clin\\ oncol\\ 2013\\;\\ 43\\:563\\.\ \(0\)\
\-\ 7\\.\\	malignant\\ pleural\\ mesothelioma\\.\\ fort\\ washington\\,\\ pa\\.\\:\\ national\\ comprehensive\\ cancer\\ network\\.\\ http\\:\\/\\/www\\.nccn\\.org\\/professionals\\/physician\\_gls\\/f\\_guidelines\\.asp\\.\\ \\ \\ accessed\\ sept\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 8\\.\\	niederhuber\\ \\ je\\,\\ et\\ al\\.\\,\\ eds\\.\\ diseases\\ of\\ the\\ pleura\\ and\\ mediastinum\\.\\ in\\:\\ abeloff\\ s\\ clinical\\ oncology\\.\\ 5th\\ ed\\.\\ philadelphia\\,\\ pa\\.\\:\\ churchill\\ livingstone\\ elsevier\\;\\ 2014\\.\\ http\\:\\/\\/www\\.clinicalkey\\.com\\.\\ \\ \\ accessed\\ \\ \\ sept\\.\\ \\ 17\\,\\ 2015\\.\ \(0\)\
\-\ 9\\.\\	osha\\ fact\\ sheet\\:\\ asbestos\\.\\ occupational\\ safety\\ and\\ health\\ administration\\.\\ http\\:\\/\\/www\\.osha\\.gov\\/sl\\ tc\\/asbestos\\/hazards\\.html\\.\\ accessed\\ oct\\.\\ 7\\,\\ 2015\\.\ \(0\)\
\-\ 10\\.\\	presentation\\,\\ initial\\ evaluation\\,\\ and\\ prognosis\\ of\\ malignant\\ pleural\ \(0\)\
\-\ mesothelioma\\.\\ \\"malignant\\ mesothelioma\\ i\\ ct\\.\\ ed\\.\\ uptodate\\ \\.\\.\\ \\.\\ uptodate\\,\\ 5\\ oct\\ 2016\\.\\ web\\.\\ 05\\ june\\ 2017\\.\ \(0\)\
\-\ 11\\.\\	husain\\ an\\,\\ colby\\ t\\,\\ ordonez\\ n\\,\\ et\\ al\\.\\ guidelines\\ for\\ pathologic\\ diagnosis\\ of\\ malignant\\ mesothelioma\\:\\ 2012\\ update\\ of\\ the\\ consensus\\ statement\\ from\\ the\\ international\\ mesothelioma\\ interest\\ group\\.\\ arch\\ pathol\\ lab\\ med\\ 2013\\;\\ 137\\:647\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mesothelioma\\:\\ 0\\.41401353367174726\ \(0\)\
\-\ asbestos\\:\\ 0\\.2659711900522983\ \(0\)\
\-\ the\\:\\ 0\\.2093792987035233\ \(0\)\
\-\ pleural\\:\\ 0\\.19477681456804202\ \(0\)\
\-\ plant\\:\\ 0\\.17572827218091752\ \(0\)\
\-\ malignant\\:\\ 0\\.17419168998787907\ \(0\)\
\-\ he\\:\\ 0\\.17023961328994036\ \(0\)\
\-\ of\\:\\ 0\\.14908913006553592\ \(0\)\
\-\ and\\:\\ 0\\.1336630297183492\ \(0\)\
\-\ is\\:\\ 0\\.114159123489349\ \(0\)\
\-\ factory\\:\\ 0\\.10620553167306304\ \(0\)\
\-\ was\\:\\ 0\\.10520188531642674\ \(0\)\
\-\ md\\:\\ 0\\.10483851091177541\ \(0\)\
\-\ his\\:\\ 0\\.10461257617087365\ \(0\)\
\-\ in\\:\\ 0\\.10012461548563213\ \(0\)\
\-\ 2012\\:\\ 0\\.09422602917456872\ \(0\)\
\-\ vats\\:\\ 0\\.09345990759169467\ \(0\)\
\-\ there\\:\\ 0\\.09151233620502575\ \(0\)\
\-\ to\\:\\ 0\\.08983916630264988\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.08271523494061782\ \(0\)\
\-\ exposure\\:\\ 0\\.08196529088602773\ \(0\)\
\-\ pet\\:\\ 0\\.07987654747665056\ \(0\)\
\-\ no\\:\\ 0\\.07946453935243206\ \(0\)\
\-\ as\\:\\ 0\\.07507107943080071\ \(0\)\
\-\ that\\:\\ 0\\.07485529996141896\ \(0\)\
\-\ patient\\:\\ 0\\.07480422492327356\ \(0\)\
\-\ effusion\\:\\ 0\\.0747187196027052\ \(0\)\
\-\ this\\:\\ 0\\.0740894351256472\ \(0\)\
\-\ paraneoplastic\\:\\ 0\\.07099117830873981\ \(0\)\
\-\ dc\\:\\ 0\\.06944319933682547\ \(0\)\
\-\ worked\\:\\ 0\\.06874198791090719\ \(0\)\
\-\ al\\:\\ 0\\.06852789884235212\ \(0\)\
\-\ et\\:\\ 0\\.0675617148526016\ \(0\)\
\-\ from\\:\\ 0\\.06279783561918885\ \(0\)\
\-\ fdg\\:\\ 0\\.06227237859847993\ \(0\)\
\-\ right\\:\\ 0\\.06195412045010431\ \(0\)\
\-\ or\\:\\ 0\\.060007088280686294\ \(0\)\
\-\ med\\:\\ 0\\.05783786010998945\ \(0\)\
\-\ recalls\\:\\ 0\\.057592949859567324\ \(0\)\
\-\ oncol\\:\\ 0\\.05679645856932188\ \(0\)\
\-\ for\\:\\ 0\\.05663793360025951\ \(0\)\
\-\ tomography\\:\\ 0\\.055691698552261006\ \(0\)\
\-\ breath\\:\\ 0\\.052676790603824256\ \(0\)\
\-\ lung\\:\\ 0\\.05246460733985155\ \(0\)\
\-\ sternotomy\\:\\ 0\\.05155649093318039\ \(0\)\
\-\ part\\:\\ 0\\.05137724639574734\ \(0\)\
\-\ with\\:\\ 0\\.05066429800252894\ \(0\)\
\-\ may\\:\\ 0\\.05063548730833181\ \(0\)\
\-\ states\\:\\ 0\\.05051521991025849\ \(0\)\
\-\ ct\\:\\ 0\\.04925215127905194\ \(0\)\
\-\ at\\:\\ 0\\.04886446618096694\ \(0\)\
\-\ accessed\\:\\ 0\\.048747591084661916\ \(0\)\
\-\ 2015\\:\\ 0\\.048491306361045136\ \(0\)\
\-\ 2013\\:\\ 0\\.04711301458728436\ \(0\)\
\-\ 17\\:\\ 0\\.046936628320324913\ \(0\)\
\-\ chemical\\:\\ 0\\.04690588723823676\ \(0\)\
\-\ sided\\:\\ 0\\.04623166776566118\ \(0\)\
\-\ pleura\\:\\ 0\\.04594768549695823\ \(0\)\
\-\ which\\:\\ 0\\.04575321380082301\ \(0\)\
\-\ chest\\:\\ 0\\.04552515561146324\ \(0\)\
\-\ same\\:\\ 0\\.04548265470919683\ \(0\)\
\-\ diagnosis\\:\\ 0\\.04470945886173857\ \(0\)\
\-\ years\\:\\ 0\\.044056511598837646\ \(0\)\
\-\ an\\:\\ 0\\.0439737159143219\ \(0\)\
\-\ manufacturing\\:\\ 0\\.04393206804522938\ \(0\)\
\-\ husain\\:\\ 0\\.04393206804522938\ \(0\)\
\-\ colby\\:\\ 0\\.04393206804522938\ \(0\)\
\-\ ordonez\\:\\ 0\\.04393206804522938\ \(0\)\
\-\ osha\\:\\ 0\\.04393206804522938\ \(0\)\
\-\ minimal\\:\\ 0\\.04386461308027882\ \(0\)\
\-\ fibers\\:\\ 0\\.0436390993767247\ \(0\)\
\-\ are\\:\\ 0\\.04363538637317784\ \(0\)\
\-\ used\\:\\ 0\\.04304468424931855\ \(0\)\
\-\ metabolically\\:\\ 0\\.042482212669225215\ \(0\)\
\-\ dust\\:\\ 0\\.04135761747030891\ \(0\)\
\-\ statement\\:\\ 0\\.04135761747030891\ \(0\)\
\-\ rep\\:\\ 0\\.04135761747030891\ \(0\)\
\-\ be\\:\\ 0\\.04081777789155044\ \(0\)\
\-\ then\\:\\ 0\\.04070143811055831\ \(0\)\
\-\ update\\:\\ 0\\.04043875628780172\ \(0\)\
\-\ unilateral\\:\\ 0\\.039465640138463334\ \(0\)\
\-\ thickening\\:\\ 0\\.03911650810720634\ \(0\)\
\-\ on\\:\\ 0\\.0390717842096291\ \(0\)\
\-\ rind\\:\\ 0\\.03898890091179756\ \(0\)\
\-\ positron\\:\\ 0\\.03898890091179756\ \(0\)\
\-\ sept\\:\\ 0\\.03898890091179756\ \(0\)\
\-\ epithelioid\\:\\ 0\\.038395299906378216\ \(0\)\
\-\ noted\\:\\ 0\\.03810637495129748\ \(0\)\
\-\ mediport\\:\\ 0\\.037864305712881255\ \(0\)\
\-\ often\\:\\ 0\\.037517127008059196\ \(0\)\
\-\ pathol\\:\\ 0\\.037383963036677875\ \(0\)\
\-\ image\\:\\ 0\\.036771776073684447\ \(0\)\
\-\ oncologist\\:\\ 0\\.03654204660904597\ \(0\)\
\-\ emission\\:\\ 0\\.03654204660904597\ \(0\)\
\-\ disease\\:\\ 0\\.03620312329000496\ \(0\)\
\-\ consensus\\:\\ 0\\.036168558470156646\ \(0\)\
\-\ case\\:\\ 0\\.03610765989050551\ \(0\)\
\-\ interest\\:\\ 0\\.03582084933145775\ \(0\)\
\-\ work\\:\\ 0\\.03515914920006158\ \(0\)\
\-\ clearance\\:\\ 0\\.03490198814895056\ \(0\)\
\-\ guidelines\\:\\ 0\\.03490198814895056\ \(0\)\
\-\ international\\:\\ 0\\.03490198814895056\ \(0\)\
\-\ mediastinal\\:\\ 0\\.03482123036055862\ \(0\)\
\-\ transfusions\\:\\ 0\\.03462950105666762\ \(0\)\
\-\ shortness\\:\\ 0\\.03457734871654624\ \(0\)\
\-\ following\\:\\ 0\\.0344930453701438\ \(0\)\
\-\ include\\:\\ 0\\.03421049984539057\ \(0\)\
\-\ people\\:\\ 0\\.033452132772946404\ \(0\)\
\-\ uptodate\\:\\ 0\\.033452132772946404\ \(0\)\
\-\ oct\\:\\ 0\\.03324639875653729\ \(0\)\
\-\ uptake\\:\\ 0\\.033159164104441724\ \(0\)\
\-\ pa\\:\\ 0\\.03309314031950226\ \(0\)\
\-\ note\\:\\ 0\\.032462802428007004\ \(0\)\
\-\ active\\:\\ 0\\.03202230840115937\ \(0\)\
\-\ http\\:\\ 0\\.03188100194449167\ \(0\)\
\-\ did\\:\\ 0\\.030934809221343135\ \(0\)\
\-\ surgery\\:\\ 0\\.03091309768473\ \(0\)\
\-\ iv\\:\\ 0\\.030812283438330035\ \(0\)\
\-\ healed\\:\\ 0\\.03051320171756439\ \(0\)\
\-\ products\\:\\ 0\\.030397339521822556\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.03006492564083845\ \(0\)\
\-\ abuse\\:\\ 0\\.029958821015518746\ \(0\)\
\-\ ipsilateral\\:\\ 0\\.029753086999109626\ \(0\)\
\-\ given\\:\\ 0\\.029664336915614483\ \(0\)\
\-\ outpatient\\:\\ 0\\.029459424314544538\ \(0\)\
\-\ followed\\:\\ 0\\.029120530674938885\ \(0\)\
\-\ initial\\:\\ 0\\.02892865044198035\ \(0\)\
\-\ 77\\:\\ 0\\.0287509217125569\ \(0\)\
\-\ white\\:\\ 0\\.028451425132723224\ \(0\)\
\-\ up\\:\\ 0\\.028441855669400884\ \(0\)\
\-\ findings\\:\\ 0\\.02837733147129558\ \(0\)\
\-\ axillary\\:\\ 0\\.028278095493449576\ \(0\)\
\-\ air\\:\\ 0\\.02820641420980177\ \(0\)\
\-\ well\\:\\ 0\\.027840581753367417\ \(0\)\
\-\ computed\\:\\ 0\\.027709630617686127\ \(0\)\
\-\ fact\\:\\ 0\\.027576997080181638\ \(0\)\
\-\ approximately\\:\\ 0\\.027515702875684913\ \(0\)\
\-\ equal\\:\\ 0\\.027511966712767157\ \(0\)\
\-\ clinical\\:\\ 0\\.02732941808257921\ \(0\)\
\-\ group\\:\\ 0\\.027321763628675905\ \(0\)\
\-\ minor\\:\\ 0\\.027019889960136732\ \(0\)\
\-\ smoking\\:\\ 0\\.026625515825550186\ \(0\)\
\-\ images\\:\\ 0\\.026596430157586334\ \(0\)\
\-\ develop\\:\\ 0\\.026465509258091092\ \(0\)\
\-\ overall\\:\\ 0\\.026413283054470455\ \(0\)\
\-\ hilar\\:\\ 0\\.02636159251366041\ \(0\)\
\-\ pulmonary\\:\\ 0\\.026285541040107264\ \(0\)\
\-\ has\\:\\ 0\\.02626319097812849\ \(0\)\
\-\ when\\:\\ 0\\.026048871005771305\ \(0\)\
\-\ lab\\:\\ 0\\.02596611255711688\ \(0\)\
\-\ represents\\:\\ 0\\.02568862319787367\ \(0\)\
\-\ home\\:\\ 0\\.02542561829756707\ \(0\)\
\-\ prognosis\\:\\ 0\\.02529908988927521\ \(0\)\
\-\ 34\\:\\ 0\\.0250551817988247\ \(0\)\
\-\ who\\:\\ 0\\.024393109378322318\ \(0\)\
\-\ arch\\:\\ 0\\.024387175342669647\ \(0\)\
\-\ these\\:\\ 0\\.02435162957426388\ \(0\)\
\-\ patients\\:\\ 0\\.02425912389529635\ \(0\)\
\-\ report\\:\\ 0\\.02421631886025847\ \(0\)\
\-\ represent\\:\\ 0\\.023922656175693377\ \(0\)\
\-\ under\\:\\ 0\\.023797437720765466\ \(0\)\
\-\ pathologic\\:\\ 0\\.023555964778965308\ \(0\)\
\-\ acute\\:\\ 0\\.023327969321771804\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.023241768895122077\ \(0\)\
\-\ distress\\:\\ 0\\.023159372778386218\ \(0\)\
\-\ cxr\\:\\ 0\\.022998514968031975\ \(0\)\
\-\ ed\\:\\ 0\\.022998514968031975\ \(0\)\
\-\ nathan\\:\\ 0\\.022987762213326438\ \(0\)\
\-\ kronenwetter\\:\\ 0\\.022987762213326438\ \(0\)\
\-\ limited\\:\\ 0\\.022946016748027587\ \(0\)\
\-\ currently\\:\\ 0\\.02208405342225005\ \(0\)\
\-\ wheezez\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ coolness\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ muslce\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ supervision\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ basolateral\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ quadruple\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ almethicone\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ senna\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ alprazolam\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ isosorbide\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ mononitrate\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ fluoxetine\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ ferrous\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ tape\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ histroy\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ adject\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ stacks\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ fifties\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ benches\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ venting\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ sucked\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ 1960s\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ plants\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ downwind\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ factories\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ coworker\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ propsed\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ plueral\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ exersion\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ insulation\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ flooring\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ investigating\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ socola\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ newland\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ leukocytoclastic\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ ty\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ kuss\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ ren\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ bech\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ s0rensen\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ tanriverdi\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ meydan\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ barutca\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ jpn\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ niederhuber\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ abeloff\\:\\ 0\\.02196603402261469\ \(0\)\
\-\ pressure\\:\\ 0\\.021889776468768173\ \(0\)\
\-\ base\\:\\ 0\\.02186864526989146\ \(0\)\
\-\ extremities\\:\\ 0\\.021847602301747125\ \(0\)\
\-\ failure\\:\\ 0\\.021826646830604476\ \(0\)\
\-\ moderate\\:\\ 0\\.021581750870131457\ \(0\)\
\-\ process\\:\\ 0\\.02156187004139704\ \(0\)\
\-\ have\\:\\ 0\\.021542373128876396\ \(0\)\
\-\ its\\:\\ 0\\.02127270181332666\ \(0\)\
\-\ unlabored\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ 125mg\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ tamsulosin\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ sober\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ opthalmologic\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ settle\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ sf\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ jy\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ yong\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ fort\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ washington\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ sheet\\:\\ 0\\.021241106334612608\ \(0\)\
\-\ 40\\:\\ 0\\.021143232363827646\ \(0\)\
\-\ after\\:\\ 0\\.02091974147457362\ \(0\)\
\-\ diagnosed\\:\\ 0\\.020824824374809252\ \(0\)\
\-\ managing\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ cholecystecomy\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ ranitidine\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ nitroglycerin\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ apartment\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ plastics\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ building\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ retirement\\:\\ 0\\.020678808735154455\ \(0\)\
\-\ risk\\:\\ 0\\.020541522292220026\ \(0\)\
\-\ non\\:\\ 0\\.020461052678724174\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.020413520909038613\ \(0\)\
\-\ would\\:\\ 0\\.020350719055279156\ \(0\)\
\-\ obtained\\:\\ 0\\.02033514011382059\ \(0\)\
\-\ lipitor\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ mile\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ brakes\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ shingles\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ clothing\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ biological\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ wong\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ thorac\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ network\\:\\ 0\\.02021937814390086\ \(0\)\
\-\ encompassing\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ erect\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ atenolol\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ vent\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ stating\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ talking\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ naturally\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ mineral\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ fluorodeoxyglucose\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ targeted\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ thrombocytopenic\\:\\ 0\\.01983093511379215\ \(0\)\
\-\ underwent\\:\\ 0\\.019804145920323625\ \(0\)\
\-\ presentation\\:\\ 0\\.019790165929254713\ \(0\)\
\-\ 2l\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ oxycodone\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ allopurinol\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ sulfate\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ remembers\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ coating\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ park\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ inhaled\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ plural\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ integrated\\:\\ 0\\.01949445045589878\ \(0\)\
\-\ type\\:\\ 0\\.01928576696132023\ \(0\)\
\-\ male\\:\\ 0\\.019200080201297955\ \(0\)\
\-\ rheumatic\\:\\ 0\\.019197649953189108\ \(0\)\
\-\ occupies\\:\\ 0\\.019197649953189108\ \(0\)\
\-\ lived\\:\\ 0\\.019197649953189108\ \(0\)\
\-\ jb\\:\\ 0\\.019197649953189108\ \(0\)\
\-\ cancer\\:\\ 0\\.019148706304118784\ \(0\)\
\-\ cataract\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ 10mg\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ withdrawal\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ house\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ respiration\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ plays\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ pursued\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ cured\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ je\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ livingstone\\:\\ 0\\.018932152856440627\ \(0\)\
\-\ dullness\\:\\ 0\\.018691981518338938\ \(0\)\
\-\ predisposition\\:\\ 0\\.018691981518338938\ \(0\)\
\-\ sc\\:\\ 0\\.018691981518338938\ \(0\)\
\-\ churchill\\:\\ 0\\.018691981518338938\ \(0\)\
\-\ found\\:\\ 0\\.01860175758953335\ \(0\)\
\-\ postsurgical\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ address\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ avulsed\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ plavix\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ adhesive\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ daughter\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ vacuum\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ swallowed\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ someone\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ safety\\:\\ 0\\.018472722265187033\ \(0\)\
\-\ by\\:\\ 0\\.01831258570159664\ \(0\)\
\-\ think\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ pshx\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ hemicolectomy\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ quit\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ son\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ carry\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ john\\:\\ 0\\.018271023304522984\ \(0\)\
\-\ medical\\:\\ 0\\.018270986440273928\ \(0\)\
\-\ during\\:\\ 0\\.0182093997242054\ \(0\)\
\-\ some\\:\\ 0\\.0180884391127038\ \(0\)\
\-\ thoracotomy\\:\\ 0\\.018084279235078323\ \(0\)\
\-\ cad\\:\\ 0\\.018084279235078323\ \(0\)\
\-\ grown\\:\\ 0\\.018084279235078323\ \(0\)\
\-\ occuring\\:\\ 0\\.018084279235078323\ \(0\)\
\-\ bj\\:\\ 0\\.018084279235078323\ \(0\)\
\-\ bronchitis\\:\\ 0\\.017910424665728876\ \(0\)\
\-\ understood\\:\\ 0\\.017910424665728876\ \(0\)\
\-\ encasement\\:\\ 0\\.017910424665728876\ \(0\)\
\-\ trials\\:\\ 0\\.017910424665728876\ \(0\)\
\-\ eds\\:\\ 0\\.017910424665728876\ \(0\)\
\-\ broken\\:\\ 0\\.017747794577184953\ \(0\)\
\-\ fail\\:\\ 0\\.017747794577184953\ \(0\)\
\-\ year\\:\\ 0\\.01771960308086472\ \(0\)\
\-\ primary\\:\\ 0\\.017677385434854587\ \(0\)\
\-\ weighs\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ asbestosis\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ former\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ discovery\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ variation\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ national\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ elsevier\\:\\ 0\\.017595027091346034\ \(0\)\
\-\ yielded\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ wires\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ thrombotic\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ comprehensive\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ 05\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ 2017\\:\\ 0\\.01745099407447528\ \(0\)\
\-\ changes\\:\\ 0\\.017374551167141875\ \(0\)\
\-\ syndrome\\:\\ 0\\.017331512617381594\ \(0\)\
\-\ 600\\:\\ 0\\.01731475052833381\ \(0\)\
\-\ polyneuropathy\\:\\ 0\\.01731475052833381\ \(0\)\
\-\ abnormal\\:\\ 0\\.017271869512424206\ \(0\)\
\-\ tall\\:\\ 0\\.017185496977726797\ \(0\)\
\-\ vertex\\:\\ 0\\.017185496977726797\ \(0\)\
\-\ issue\\:\\ 0\\.017185496977726797\ \(0\)\
\-\ plastic\\:\\ 0\\.01706255104436657\ \(0\)\
\-\ conjunction\\:\\ 0\\.01706255104436657\ \(0\)\
\-\ time\\:\\ 0\\.01704011449522204\ \(0\)\
\-\ however\\:\\ 0\\.01701590411936629\ \(0\)\
\-\ lives\\:\\ 0\\.016945325639625107\ \(0\)\
\-\ irritation\\:\\ 0\\.016945325639625107\ \(0\)\
\-\ scars\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ excess\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ hoarseness\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ curative\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ therapies\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ gene\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ occupational\\:\\ 0\\.01683331200876706\ \(0\)\
\-\ 10\\:\\ 0\\.016810814205910147\ \(0\)\
\-\ bmi\\:\\ 0\\.016726066386473202\ \(0\)\
\-\ living\\:\\ 0\\.016726066386473202\ \(0\)\
\-\ blood\\:\\ 0\\.01669618188989486\ \(0\)\
\-\ resistant\\:\\ 0\\.016623199378268644\ \(0\)\
\-\ aspirin\\:\\ 0\\.016524367425809157\ \(0\)\
\-\ etoh\\:\\ 0\\.016524367425809157\ \(0\)\
\-\ illicit\\:\\ 0\\.016524367425809157\ \(0\)\
\-\ phenomenon\\:\\ 0\\.016524367425809157\ \(0\)\
\-\ june\\:\\ 0\\.016524367425809157\ \(0\)\
\-\ therapy\\:\\ 0\\.01651802666102521\ \(0\)\
\-\ history\\:\\ 0\\.016475535395067954\ \(0\)\
\-\ seated\\:\\ 0\\.016429265883763533\ \(0\)\
\-\ specificity\\:\\ 0\\.016429265883763533\ \(0\)\
\-\ ppd\\:\\ 0\\.016337623356364493\ \(0\)\
\-\ mascaro\\:\\ 0\\.016337623356364493\ \(0\)\
\-\ terms\\:\\ 0\\.016337623356364493\ \(0\)\
\-\ evidence\\:\\ 0\\.01631783872767706\ \(0\)\
\-\ mild\\:\\ 0\\.016296854171827056\ \(0\)\
\-\ decades\\:\\ 0\\.016249197028220638\ \(0\)\
\-\ gradual\\:\\ 0\\.016249197028220638\ \(0\)\
\-\ clips\\:\\ 0\\.01616376878701505\ \(0\)\
\-\ working\\:\\ 0\\.01616376878701505\ \(0\)\
\-\ incision\\:\\ 0\\.01608114198220067\ \(0\)\
\-\ orientation\\:\\ 0\\.01608114198220067\ \(0\)\
\-\ lieberman\\:\\ 0\\.016001138698471123\ \(0\)\
\-\ ongoing\\:\\ 0\\.016001138698471123\ \(0\)\
\-\ xray\\:\\ 0\\.015923597448913356\ \(0\)\
\-\ heat\\:\\ 0\\.015923597448913356\ \(0\)\
\-\ infiltrates\\:\\ 0\\.015848371212632203\ \(0\)\
\-\ hyperlipidemia\\:\\ 0\\.01577532575690634\ \(0\)\
\-\ bypass\\:\\ 0\\.01577532575690634\ \(0\)\
\-\ exact\\:\\ 0\\.01577532575690634\ \(0\)\
\-\ surgeons\\:\\ 0\\.01577532575690634\ \(0\)\
\-\ symptoms\\:\\ 0\\.015729692455660877\ \(0\)\
\-\ clubbing\\:\\ 0\\.015704338195761454\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.015704338195761454\ \(0\)\
\-\ congestive\\:\\ 0\\.015704338195761454\ \(0\)\
\-\ jeffrey\\:\\ 0\\.015704338195761454\ \(0\)\
\-\ normocephalic\\:\\ 0\\.01563529574607892\ \(0\)\
\-\ consistent\\:\\ 0\\.015588237139833197\ \(0\)\
\-\ physical\\:\\ 0\\.015588237139833197\ \(0\)\
\-\ myocardial\\:\\ 0\\.015502639235097405\ \(0\)\
\-\ rash\\:\\ 0\\.015502639235097405\ \(0\)\
\-\ roof\\:\\ 0\\.015502639235097405\ \(0\)\
\-\ remove\\:\\ 0\\.015502639235097405\ \(0\)\
\-\ web\\:\\ 0\\.015502639235097405\ \(0\)\
\-\ gerd\\:\\ 0\\.015438841099012968\ \(0\)\
\-\ production\\:\\ 0\\.015438841099012968\ \(0\)\
\-\ projecting\\:\\ 0\\.015376618387659033\ \(0\)\
\-\ fingers\\:\\ 0\\.015376618387659033\ \(0\)\
\-\ percussion\\:\\ 0\\.015376618387659033\ \(0\)\
\-\ oncology\\:\\ 0\\.015376618387659033\ \(0\)\
\-\ copd\\:\\ 0\\.015315895165652743\ \(0\)\
\-\ 2010\\:\\ 0\\.015315895165652743\ \(0\)\
\-\ rhonchi\\:\\ 0\\.015256600858782195\ \(0\)\
\-\ doing\\:\\ 0\\.015256600858782195\ \(0\)\
\-\ jennifer\\:\\ 0\\.015256600858782195\ \(0\)\
\-\ sperrazza\\:\\ 0\\.015256600858782195\ \(0\)\
\-\ pmhx\\:\\ 0\\.015198669760911278\ \(0\)\
\-\ kg\\:\\ 0\\.015142040596303297\ \(0\)\
\-\ never\\:\\ 0\\.015142040596303297\ \(0\)\
\-\ imaging\\:\\ 0\\.015108445832105692\ \(0\)\
\-\ died\\:\\ 0\\.01508665613005323\ \(0\)\
\-\ role\\:\\ 0\\.01508665613005323\ \(0\)\
\-\ clin\\:\\ 0\\.01508665613005323\ \(0\)\
\-\ can\\:\\ 0\\.015086438008710935\ \(0\)\
\-\ tumor\\:\\ 0\\.015037268998722852\ \(0\)\
\-\ allergies\\:\\ 0\\.015032462820419226\ \(0\)\
\-\ lutnick\\:\\ 0\\.015032462820419226\ \(0\)\
\-\ ultimately\\:\\ 0\\.015032462820419226\ \(0\)\
\-\ strong\\:\\ 0\\.014979410507759373\ \(0\)\
\-\ other\\:\\ 0\\.014929692159783705\ \(0\)\
\-\ gallops\\:\\ 0\\.014927452135544033\ \(0\)\
\-\ cyanosis\\:\\ 0\\.014927452135544033\ \(0\)\
\-\ reconstruction\\:\\ 0\\.014927452135544033\ \(0\)\
\-\ social\\:\\ 0\\.014927452135544033\ \(0\)\
\-\ pack\\:\\ 0\\.014927452135544033\ \(0\)\
\-\ median\\:\\ 0\\.014876543499554813\ \(0\)\
\-\ croce\\:\\ 0\\.014876543499554813\ \(0\)\
\-\ gary\\:\\ 0\\.014876543499554813\ \(0\)\
\-\ jugular\\:\\ 0\\.014826643021920454\ \(0\)\
\-\ scarring\\:\\ 0\\.014826643021920454\ \(0\)\
\-\ iqbal\\:\\ 0\\.014826643021920454\ \(0\)\
\-\ unfortunately\\:\\ 0\\.014826643021920454\ \(0\)\
\-\ were\\:\\ 0\\.014819154616992234\ \(0\)\
\-\ correction\\:\\ 0\\.014777711547095326\ \(0\)\
\-\ bases\\:\\ 0\\.014777711547095326\ \(0\)\
\-\ robert\\:\\ 0\\.014777711547095326\ \(0\)\
\-\ scott\\:\\ 0\\.014777711547095326\ \(0\)\
\-\ tirone\\:\\ 0\\.014777711547095326\ \(0\)\
\-\ present\\:\\ 0\\.01475192202819741\ \(0\)\
\-\ frank\\:\\ 0\\.014729712157272269\ \(0\)\
\-\ affects\\:\\ 0\\.014729712157272269\ \(0\)\
\-\ it\\:\\ 0\\.014716087966777742\ \(0\)\
\-\ ages\\:\\ 0\\.014682610005049704\ \(0\)\
\-\ transformation\\:\\ 0\\.014682610005049704\ \(0\)\
\-\ staging\\:\\ 0\\.014682610005049704\ \(0\)\
\-\ 2008\\:\\ 0\\.014682610005049704\ \(0\)\
\-\ hemithorax\\:\\ 0\\.014636372161453123\ \(0\)\
\-\ charles\\:\\ 0\\.014636372161453123\ \(0\)\
\-\ vaseem\\:\\ 0\\.014636372161453123\ \(0\)\
\-\ progress\\:\\ 0\\.014636372161453123\ \(0\)\
\-\ deformities\\:\\ 0\\.014590967477650664\ \(0\)\
\-\ sensitivity\\:\\ 0\\.014590967477650664\ \(0\)\
\-\ spectrum\\:\\ 0\\.014590967477650664\ \(0\)\
\-\ childhood\\:\\ 0\\.014546366458908234\ \(0\)\
\-\ rectal\\:\\ 0\\.014546366458908234\ \(0\)\
\-\ floor\\:\\ 0\\.014546366458908234\ \(0\)\
\-\ philadelphia\\:\\ 0\\.014546366458908234\ \(0\)\
\-\ gout\\:\\ 0\\.014502541149506807\ \(0\)\
\-\ rubs\\:\\ 0\\.014459465027497363\ \(0\)\
\-\ large\\:\\ 0\\.014404555394072285\ \(0\)\
\-\ htn\\:\\ 0\\.014334486103486843\ \(0\)\
\-\ had\\:\\ 0\\.0143236887980118\ \(0\)\
\-\ directly\\:\\ 0\\.014294166974940993\ \(0\)\
\-\ pupils\\:\\ 0\\.014254482819757294\ \(0\)\
\-\ tone\\:\\ 0\\.014254482819757294\ \(0\)\
\-\ morning\\:\\ 0\\.014254482819757294\ \(0\)\
\-\ facility\\:\\ 0\\.014254482819757294\ \(0\)\
\-\ but\\:\\ 0\\.014216306299714761\ \(0\)\
\-\ stated\\:\\ 0\\.014215413947637172\ \(0\)\
\-\ smith\\:\\ 0\\.014215413947637172\ \(0\)\
\-\ health\\:\\ 0\\.014215413947637172\ \(0\)\
\-\ randall\\:\\ 0\\.014176941570199528\ \(0\)\
\-\ loftus\\:\\ 0\\.014176941570199528\ \(0\)\
\-\ rales\\:\\ 0\\.014139047746724788\ \(0\)\
\-\ excluded\\:\\ 0\\.014139047746724788\ \(0\)\
\-\ assessment\\:\\ 0\\.014064927939341481\ \(0\)\
\-\ fissure\\:\\ 0\\.014028669878192509\ \(0\)\
\-\ protocol\\:\\ 0\\.014028669878192509\ \(0\)\
\-\ survival\\:\\ 0\\.014028669878192509\ \(0\)\
\-\ literature\\:\\ 0\\.014028669878192509\ \(0\)\
\-\ ms\\:\\ 0\\.013957682317047625\ \(0\)\
\-\ krishnan\\:\\ 0\\.013888639867365092\ \(0\)\
\-\ kartha\\:\\ 0\\.013888639867365092\ \(0\)\
\-\ s2\\:\\ 0\\.013821438770906155\ \(0\)\
\-\ murmurs\\:\\ 0\\.013788498540090819\ \(0\)\
\-\ joanna\\:\\ 0\\.013788498540090819\ \(0\)\
\-\ garvey\\:\\ 0\\.013788498540090819\ \(0\)\
\-\ serghany\\:\\ 0\\.013788498540090819\ \(0\)\
\-\ geoffrey\\:\\ 0\\.013755983356383578\ \(0\)\
\-\ gerow\\:\\ 0\\.013755983356383578\ \(0\)\
\-\ treatment\\:\\ 0\\.013694559418075925\ \(0\)\
\-\ thick\\:\\ 0\\.013660881814337953\ \(0\)\
\-\ suspicion\\:\\ 0\\.013660881814337953\ \(0\)\
\-\ rhythm\\:\\ 0\\.013629962508945204\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.013629962508945204\ \(0\)\
\-\ li\\:\\ 0\\.013629962508945204\ \(0\)\
\-\ joseph\\:\\ 0\\.013599417992245696\ \(0\)\
\-\ mechanism\\:\\ 0\\.01353941773446022\ \(0\)\
\-\ also\\:\\ 0\\.01352259236193863\ \(0\)\
\-\ significantly\\:\\ 0\\.013509944980068366\ \(0\)\
\-\ feet\\:\\ 0\\.013509944980068366\ \(0\)\
\-\ nonspecific\\:\\ 0\\.013509944980068366\ \(0\)\
\-\ once\\:\\ 0\\.013509944980068366\ \(0\)\
\-\ peritoneal\\:\\ 0\\.013509944980068366\ \(0\)\
\-\ factor\\:\\ 0\\.013480812958795059\ \(0\)\
\-\ confirm\\:\\ 0\\.01345201388219745\ \(0\)\
\-\ began\\:\\ 0\\.013367540326274867\ \(0\)\
\-\ degeneration\\:\\ 0\\.013367540326274867\ \(0\)\
\-\ 5th\\:\\ 0\\.013367540326274867\ \(0\)\
\-\ anatomic\\:\\ 0\\.013340000251339402\ \(0\)\
\-\ older\\:\\ 0\\.013340000251339402\ \(0\)\
\-\ vasculitis\\:\\ 0\\.013340000251339402\ \(0\)\
\-\ alcohol\\:\\ 0\\.013285806941705397\ \(0\)\
\-\ within\\:\\ 0\\.013240791933273936\ \(0\)\
\-\ movement\\:\\ 0\\.013232754629045546\ \(0\)\
\-\ diseases\\:\\ 0\\.013206641527235228\ \(0\)\
\-\ 41\\:\\ 0\\.013180796256830205\ \(0\)\
\-\ progression\\:\\ 0\\.013180796256830205\ \(0\)\
\-\ extent\\:\\ 0\\.013155213379487777\ \(0\)\
\-\ arise\\:\\ 0\\.013155213379487777\ \(0\)\
\-\ definitive\\:\\ 0\\.013129887620840984\ \(0\)\
\-\ osteoarthritis\\:\\ 0\\.013129887620840984\ \(0\)\
\-\ discovered\\:\\ 0\\.013104813863971927\ \(0\)\
\-\ expansion\\:\\ 0\\.013104813863971927\ \(0\)\
\-\ residual\\:\\ 0\\.013079987143206625\ \(0\)\
\-\ drug\\:\\ 0\\.013079987143206625\ \(0\)\
\-\ hearing\\:\\ 0\\.013055402638212584\ \(0\)\
\-\ interstitial\\:\\ 0\\.013031055668381497\ \(0\)\
\-\ dysphagia\\:\\ 0\\.01298305627855844\ \(0\)\
\-\ poorly\\:\\ 0\\.01298305627855844\ \(0\)\
\-\ asymmetric\\:\\ 0\\.012935954126335874\ \(0\)\
\-\ night\\:\\ 0\\.012912729152949862\ \(0\)\
\-\ mediastinum\\:\\ 0\\.012866911676653341\ \(0\)\
\-\ heent\\:\\ 0\\.012844311598936835\ \(0\)\
\-\ suspicious\\:\\ 0\\.012844311598936835\ \(0\)\
\-\ gallbladder\\:\\ 0\\.012844311598936835\ \(0\)\
\-\ observed\\:\\ 0\\.012799710580194405\ \(0\)\
\-\ catheter\\:\\ 0\\.012777702651881247\ \(0\)\
\-\ leading\\:\\ 0\\.012777702651881247\ \(0\)\
\-\ improved\\:\\ 0\\.012755885270792978\ \(0\)\
\-\ become\\:\\ 0\\.012755885270792978\ \(0\)\
\-\ relative\\:\\ 0\\.012734255165671829\ \(0\)\
\-\ visible\\:\\ 0\\.01267045702958739\ \(0\)\
\-\ dyspnea\\:\\ 0\\.012649544944637605\ \(0\)\
\-\ ordered\\:\\ 0\\.012628804977564622\ \(0\)\
\-\ shift\\:\\ 0\\.012628804977564622\ \(0\)\
\-\ volume\\:\\ 0\\.012628804977564622\ \(0\)\
\-\ physician\\:\\ 0\\.012608234318233455\ \(0\)\
\-\ s1\\:\\ 0\\.012547511096227166\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.01252759089941235\ \(0\)\
\-\ light\\:\\ 0\\.012449448458923816\ \(0\)\
\-\ gait\\:\\ 0\\.012449448458923816\ \(0\)\
\-\ regular\\:\\ 0\\.012411267550085694\ \(0\)\
\-\ decrease\\:\\ 0\\.012355059455204546\ \(0\)\
\-\ short\\:\\ 0\\.012355059455204546\ \(0\)\
\-\ reactive\\:\\ 0\\.0123365986270379\ \(0\)\
\-\ regions\\:\\ 0\\.0123365986270379\ \(0\)\
\-\ overlying\\:\\ 0\\.012246270254440151\ \(0\)\
\-\ incidentally\\:\\ 0\\.012246270254440151\ \(0\)\
\-\ few\\:\\ 0\\.012193587671334823\ \(0\)\
\-\ generally\\:\\ 0\\.012176268759351423\ \(0\)\
\-\ factors\\:\\ 0\\.012159068066118455\ \(0\)\
\-\ poor\\:\\ 0\\.01212501495634922\ \(0\)\
\-\ even\\:\\ 0\\.01209141590158808\ \(0\)\
\-\ gi\\:\\ 0\\.012074782892192324\ \(0\)\
\-\ medications\\:\\ 0\\.012058258952494873\ \(0\)\
\-\ strength\\:\\ 0\\.01204184266137699\ \(0\)\
\-\ necessary\\:\\ 0\\.01202553262531486\ \(0\)\
\-\ resulting\\:\\ 0\\.011961328087846688\ \(0\)\
\-\ until\\:\\ 0\\.011961328087846688\ \(0\)\
\-\ their\\:\\ 0\\.011929829030518941\ \(0\)\
\-\ point\\:\\ 0\\.011883306630231375\ \(0\)\
\-\ development\\:\\ 0\\.011883306630231375\ \(0\)\
\-\ review\\:\\ 0\\.011837627582905932\ \(0\)\
\-\ children\\:\\ 0\\.011777982389482654\ \(0\)\
\-\ another\\:\\ 0\\.011763289101354537\ \(0\)\
\-\ cerebellar\\:\\ 0\\.011763289101354537\ \(0\)\
\-\ bleeding\\:\\ 0\\.011748680992186808\ \(0\)\
\-\ normal\\:\\ 0\\.011737925572889723\ \(0\)\
\-\ skull\\:\\ 0\\.01166276726947035\ \(0\)\
\-\ rupture\\:\\ 0\\.011620884447561038\ \(0\)\
\-\ denies\\:\\ 0\\.011593344372625573\ \(0\)\
\-\ features\\:\\ 0\\.011566102034061264\ \(0\)\
\-\ general\\:\\ 0\\.01153915106299157\ \(0\)\
\-\ outside\\:\\ 0\\.01153915106299157\ \(0\)\
\-\ recurrent\\:\\ 0\\.011525782905515414\ \(0\)\
\-\ oral\\:\\ 0\\.011512485292734171\ \(0\)\
\-\ just\\:\\ 0\\.011499257484015988\ \(0\)\
\-\ appearing\\:\\ 0\\.011486098750331715\ \(0\)\
\-\ arm\\:\\ 0\\.011473008374013794\ \(0\)\
\-\ position\\:\\ 0\\.011459985648521399\ \(0\)\
\-\ procedure\\:\\ 0\\.011459985648521399\ \(0\)\
\-\ absence\\:\\ 0\\.011459985648521399\ \(0\)\
\-\ references\\:\\ 0\\.011459985648521399\ \(0\)\
\-\ stage\\:\\ 0\\.011447029878211593\ \(0\)\
\-\ administration\\:\\ 0\\.011447029878211593\ \(0\)\
\-\ respiratory\\:\\ 0\\.011434140378116376\ \(0\)\
\-\ films\\:\\ 0\\.011383231742127155\ \(0\)\
\-\ not\\:\\ 0\\.011349326232075985\ \(0\)\
\-\ nodule\\:\\ 0\\.011345714049972522\ \(0\)\
\-\ many\\:\\ 0\\.011333331264492796\ \(0\)\
\-\ increasing\\:\\ 0\\.01132100903077322\ \(0\)\
\-\ family\\:\\ 0\\.011308746759498754\ \(0\)\
\-\ pathology\\:\\ 0\\.011284399789667669\ \(0\)\
\-\ infarction\\:\\ 0\\.011284399789667669\ \(0\)\
\-\ initially\\:\\ 0\\.011272313954632478\ \(0\)\
\-\ visualized\\:\\ 0\\.0112245420637284\ \(0\)\
\-\ placement\\:\\ 0\\.0112245420637284\ \(0\)\
\-\ thin\\:\\ 0\\.011189298247622045\ \(0\)\
\-\ reports\\:\\ 0\\.011177659003952555\ \(0\)\
\-\ shown\\:\\ 0\\.011143060404025466\ \(0\)\
\-\ additional\\:\\ 0\\.011143060404025466\ \(0\)\
\-\ typical\\:\\ 0\\.011108930422586347\ \(0\)\
\-\ sounds\\:\\ 0\\.011097655720223006\ \(0\)\
\-\ complications\\:\\ 0\\.011009229392079151\ \(0\)\
\-\ attenuation\\:\\ 0\\.010998391131180027\ \(0\)\
\-\ worsening\\:\\ 0\\.010976853463533413\ \(0\)\
\-\ colon\\:\\ 0\\.010944888234384087\ \(0\)\
\-\ related\\:\\ 0\\.010923801150873562\ \(0\)\
\-\ traumatic\\:\\ 0\\.010892497744912376\ \(0\)\
\-\ rate\\:\\ 0\\.010892497744912376\ \(0\)\
\-\ change\\:\\ 0\\.010892497744912376\ \(0\)\
\-\ midline\\:\\ 0\\.010810874681108824\ \(0\)\
\-\ about\\:\\ 0\\.010761171062329638\ \(0\)\
\-\ result\\:\\ 0\\.010761171062329638\ \(0\)\
\-\ 60\\:\\ 0\\.010751346910415035\ \(0\)\
\-\ pattern\\:\\ 0\\.010731812767830804\ \(0\)\
\-\ cough\\:\\ 0\\.010731812767830804\ \(0\)\
\-\ skin\\:\\ 0\\.010693192980888637\ \(0\)\
\-\ cardiac\\:\\ 0\\.010674102800386456\ \(0\)\
\-\ referred\\:\\ 0\\.01063635090666333\ \(0\)\
\-\ course\\:\\ 0\\.01061768495631819\ \(0\)\
\-\ lungs\\:\\ 0\\.010608403576490717\ \(0\)\
\-\ tumors\\:\\ 0\\.010571616181913823\ \(0\)\
\-\ metastasis\\:\\ 0\\.010535358120764851\ \(0\)\
\-\ appears\\:\\ 0\\.010526374539861888\ \(0\)\
\-\ clear\\:\\ 0\\.010420997857633204\ \(0\)\
\-\ since\\:\\ 0\\.010412412187404626\ \(0\)\
\-\ abnormalities\\:\\ 0\\.010412412187404626\ \(0\)\
\-\ involvement\\:\\ 0\\.01040385567061155\ \(0\)\
\-\ early\\:\\ 0\\.010361503551415406\ \(0\)\
\-\ reported\\:\\ 0\\.010353117880534078\ \(0\)\
\-\ vein\\:\\ 0\\.01030338155988322\ \(0\)\
\-\ including\\:\\ 0\\.010287018568787004\ \(0\)\
\-\ care\\:\\ 0\\.010270761146110013\ \(0\)\
\-\ they\\:\\ 0\\.010270761146110013\ \(0\)\
\-\ typically\\:\\ 0\\.010090971704192103\ \(0\)\
\-\ biopsy\\:\\ 0\\.010075927529511256\ \(0\)\
\-\ being\\:\\ 0\\.01001663322264071\ \(0\)\
\-\ heart\\:\\ 0\\.009994752693492086\ \(0\)\
\-\ side\\:\\ 0\\.009930228468431479\ \(0\)\
\-\ benign\\:\\ 0\\.009874228568847211\ \(0\)\
\-\ now\\:\\ 0\\.00986731528117944\ \(0\)\
\-\ 12\\:\\ 0\\.009826229179024152\ \(0\)\
\-\ neoplasm\\:\\ 0\\.009812681341152154\ \(0\)\
\-\ although\\:\\ 0\\.009785802240703356\ \(0\)\
\-\ inferior\\:\\ 0\\.009779127026801586\ \(0\)\
\-\ fever\\:\\ 0\\.009746013649198512\ \(0\)\
\-\ size\\:\\ 0\\.009732889183205006\ \(0\)\
\-\ inflammatory\\:\\ 0\\.009719832719931038\ \(0\)\
\-\ internal\\:\\ 0\\.009687484499402547\ \(0\)\
\-\ cases\\:\\ 0\\.009668273033227861\ \(0\)\
\-\ bilaterally\\:\\ 0\\.009586675385778967\ \(0\)\
\-\ study\\:\\ 0\\.009586675385778967\ \(0\)\
\-\ radiation\\:\\ 0\\.009525658075918651\ \(0\)\
\-\ out\\:\\ 0\\.00944848221340921\ \(0\)\
\-\ revealed\\:\\ 0\\.009425203601909246\ \(0\)\
\-\ medial\\:\\ 0\\.00935663088692364\ \(0\)\
\-\ superior\\:\\ 0\\.009345381351390335\ \(0\)\
\-\ adjacent\\:\\ 0\\.009317475287960937\ \(0\)\
\-\ any\\:\\ 0\\.009289874883069297\ \(0\)\
\-\ while\\:\\ 0\\.009289874883069297\ \(0\)\
\-\ 20\\:\\ 0\\.009273458591951412\ \(0\)\
\-\ will\\:\\ 0\\.009251735252466198\ \(0\)\
\-\ day\\:\\ 0\\.009156233187209947\ \(0\)\
\-\ show\\:\\ 0\\.009125186899944392\ \(0\)\
\-\ age\\:\\ 0\\.009024377786320812\ \(0\)\
\-\ diffuse\\:\\ 0\\.009014515183615807\ \(0\)\
\-\ only\\:\\ 0\\.00898029692276123\ \(0\)\
\-\ treated\\:\\ 0\\.008951332330594947\ \(0\)\
\-\ renal\\:\\ 0\\.008951332330594947\ \(0\)\
\-\ decreased\\:\\ 0\\.008903785792201692\ \(0\)\
\-\ negative\\:\\ 0\\.008899080110583301\ \(0\)\
\-\ neck\\:\\ 0\\.008793206071264914\ \(0\)\
\-\ abdomen\\:\\ 0\\.00877076699356599\ \(0\)\
\-\ evaluation\\:\\ 0\\.008766303056571586\ \(0\)\
\-\ loss\\:\\ 0\\.008757398836089836\ \(0\)\
\-\ wall\\:\\ 0\\.008744101223308591\ \(0\)\
\-\ appearance\\:\\ 0\\.008665756308690797\ \(0\)\
\-\ weeks\\:\\ 0\\.008614847672701577\ \(0\)\
\-\ likely\\:\\ 0\\.00858977391583252\ \(0\)\
\-\ edema\\:\\ 0\\.00857319562067881\ \(0\)\
\-\ all\\:\\ 0\\.008556725681169393\ \(0\)\
\-\ chronic\\:\\ 0\\.008532220867887201\ \(0\)\
\-\ old\\:\\ 0\\.008508476375228153\ \(0\)\
\-\ presented\\:\\ 0\\.008382323963457282\ \(0\)\
\-\ been\\:\\ 0\\.008374676334599887\ \(0\)\
\-\ months\\:\\ 0\\.008367051845350797\ \(0\)\
\-\ distal\\:\\ 0\\.008351871728513935\ \(0\)\
\-\ if\\:\\ 0\\.008351871728513935\ \(0\)\
\-\ axial\\:\\ 0\\.00830315854898711\ \(0\)\
\-\ fluid\\:\\ 0\\.008299450098318733\ \(0\)\
\-\ due\\:\\ 0\\.00826266270374184\ \(0\)\
\-\ prior\\:\\ 0\\.008042490611683245\ \(0\)\
\-\ both\\:\\ 0\\.008015860067670168\ \(0\)\
\-\ over\\:\\ 0\\.00799278699290406\ \(0\)\
\-\ increased\\:\\ 0\\.007772980947567224\ \(0\)\
\-\ follow\\:\\ 0\\.0077490388028542394\ \(0\)\
\-\ into\\:\\ 0\\.007641172716229482\ \(0\)\
\-\ associated\\:\\ 0\\.007576375953448671\ \(0\)\
\-\ most\\:\\ 0\\.007480862395088466\ \(0\)\
\-\ demonstrate\\:\\ 0\\.007472841512642047\ \(0\)\
\-\ small\\:\\ 0\\.007414789082379534\ \(0\)\
\-\ exam\\:\\ 0\\.007236069855584216\ \(0\)\
\-\ lateral\\:\\ 0\\.007133688890736232\ \(0\)\
\-\ contrast\\:\\ 0\\.006984217535876581\ \(0\)\
\-\ female\\:\\ 0\\.006936301123209938\ \(0\)\
\-\ mass\\:\\ 0\\.005490629261087026\ \(0\)\
\-\ pain\\:\\ 0\\.005143681999335589\ \(0\)\
\-\ left\\:\\ 0\\.004903414370063848\ \(0\)\
